SILO
Silo Pharma
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
SILO Profile
Silo Pharma, Inc.
A developmental stage biopharmaceutical company that developing products for indications such as PTSD and Alzheimer's disease
677 N. Washington Boulevard, Sarasota, Florida 34236
--
Silo Pharma, Inc., was incorporated in New York State on July 13, 2010. On January 24, 2013, the Company changed its domicile from New York to Delaware. On December 19, 2023, the company changed its state of incorporation from Delaware to Nevada. The company is a developing biopharmaceutical company focused on combining traditional therapies with psychedelic drug research to treat people with Alzheimer's, post-traumatic stress disorder and other rare neurological disorders.